UNSPSC 51172829: Hydrofluoric acid/phosphoric acid/sodium fluoride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR100. This VA Drug Class (OR100) classifies this compound as belonging to the group CARIOSTATICS, TOPICAL.

UNSPSC 51172829 Hydrofluoric acid/phosphoric acid/sodium fluoride is a Commodity code with a mismatch between its nominal scope and the recent activity tagged to it. The single recent state and local solicitation under this code is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and over-the-counter products, a procurement focused on finished pharmaceutical goods distributed through authorized wholesalers to state and local government facilities across participating jurisdictions including Oregon. This RFP does not solicit chemical feedstocks or raw materials like hydrofluoric acid, phosphoric acid, or sodium fluoride; rather, it seeks manufacturers of pharmaceutical products with specific National Drug Codes, requiring detailed product specifications, NDC codes, SKUs, UPCs, and compliance certifications including current Good Manufacturing Practices and the Drug Supply Chain Security Act. The issuing body is the Minnesota Department of Administration's Office of State Procurement acting through MMCAP, a multistate cooperative purchasing vehicle that serves participating state and local government members.

The geographic scope includes Minnesota and Oregon as named participating jurisdictions. The representative recent opportunity is MMCAP's RFP S1070000015802 posted January 20, 2026, with proposals due March 26, 2026, seeking manufacturers to supply pharmaceutical products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with awarded vendors effective July 1, 2026. Evaluation emphasizes price competitiveness at 75 percent, with secondary weight on fixed pricing, administrative fee format compliance, EDI capability, and willingness to accept a 3 percent administrative fee. Vendors must maintain commercial general liability insurance of $5,000,000 per occurrence and meet contractual relationships with at least two authorized wholesalers with chargeback systems. The contract term is two years for new responders with optional MMCAP discretionary extensions, while incumbent responses align with existing agreement expiration through June 30, 2028. The code shows minimal recent activity aligned with its nominal chemical-materials scope.